IL17A and its receptor could play a pathogenic role in many inflammatory and autoimmune diseases including multiple sclerosis, autism spectrum disorders, epilepsy, Alzheimer’s disease, and rheumatoid arthritis41. Here, IL17A is linked to early-onset autosomal dominant Alzheimer disease.